Bioregenx (BRGX) Net Income towards Common Stockholders (2022 - 2026)
Bioregenx (BRGX) posted Net Income towards Common Stockholders of -$126850.0 for Q1 2026, up 87.54% on a QoQ basis from -$1.0 million in Q4 2025, and up 52.46% year-over-year from -$83199.6 in Q1 2025.
Powered by 
Analysis
Bioregenx (BRGX) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
Bioregenx has reported Net Income towards Common Stockholders for 5 years, with the latest figure at -$126850.0 in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 52.46% year-over-year to -$126850.0 in Q1 2026; TTM through Mar 2026 was -$1.4 million, a 93.04% increase from a year earlier, with the FY2025 full-year figure at -$1.5 million, up 93.3% from the prior year.
- Net Income towards Common Stockholders was -$126850.0 for Q1 2026 at Bioregenx, up from -$1.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$2191.0 in Q3 2022, with the low at -$18.4 million in Q4 2024.
- Average Net Income towards Common Stockholders over 5 years is -$1.4 million, with a median of -$178345.0 recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders sank 26695.74% in 2024, then soared 94.47% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$30535.0 in 2022, then tumbled by 2257.84% to -$719966.0 in 2023, then tumbled by 2455.76% to -$18.4 million in 2024, then jumped by 94.47% to -$1.0 million in 2025, then soared by 87.54% to -$126850.0 in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$126850.0 (Q1 2026), -$1.0 million (Q4 2025), and -$80565.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 249.10 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 383.43 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 | -126,850.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -126,850.00 |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -80,565.00 |
| Jun 30, 2025 | -178,345.00 |
| Mar 31, 2025 | -266,854.00 |
| Dec 31, 2024 | -18.40 Mn |
| Sep 30, 2024 | -394,860.00 |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -704,806.00 |
| Dec 31, 2023 | -719,966.00 |
| Sep 30, 2023 | -3,691.00 |
| Jun 30, 2023 | -4,128.00 |
| Mar 31, 2023 | -229,838.00 |
| Dec 31, 2022 | -30,535.00 |
| Sep 30, 2022 | -2,191.00 |
| Jun 30, 2022 | -33,263.00 |
| Mar 31, 2022 | -37,319.00 |
API Access
Bioregenx Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BRGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "BRGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BRGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();